Design, synthesis, biological evaluation and molecular docking studies of novel pleuromutilin derivatives containing nitrogen heterocycle and alkylamine groups. 2022

Qi Wang, and Jie Liu, and Zi-Dan Zhou, and Ke-Xin Zhou, and Fei Li, and Qi-Wen Zhang, and Shou-Kai Wang, and Wei Wang, and Zhen Jin, and You-Zhi Tang
Guangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricultural University, Guangzhou, China.

A series of pleuromutilin derivatives containing alkylamine and nitrogen heterocycle groups were designed and synthesised under mild conditions. The in vitro antibacterial activity of these semisynthetic derivatives against four strains of Staphylococcus aureus (MRSA ATCC 43300, S.aureus ATCC 29213, S.aureus AD3, and S.aureus 144) were evaluated by the broth dilution method. Compound 13 was found to have excellent antibacterial activity against MRSA (MIC = 0.0625 μg/mL). Furthermore, compound 13 was further studied by the time-killing kinetics and the post-antibiotic effect approach. In the mouse thigh infection model, compound 13 exhibited superior antibacterial efficacy than that of tiamulin. Meanwhile, compound 13 showed a lower inhibitory effect than that of tiamulin on RAW264.7 and 16HBE cells at the concentration of 10 μg/mL. Molecular docking study revealed that compound 13 can effectively bind to the active site of the 50S ribosome (the binding free energy = -9.66 kcal/mol).

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009584 Nitrogen An element with the atomic symbol N, atomic number 7, and atomic weight [14.00643; 14.00728]. Nitrogen exists as a diatomic gas and makes up about 78% of the earth's atmosphere by volume. It is a constituent of proteins and nucleic acids and found in all living cells.
D011083 Polycyclic Compounds Compounds which contain two or more rings in their structure. Compounds, Polycyclic
D004224 Diterpenes Twenty-carbon compounds derived from MEVALONIC ACID or deoxyxylulose phosphate. Diterpene,Diterpenes, Cembrane,Diterpenes, Labdane,Diterpenoid,Labdane Diterpene,Norditerpene,Norditerpenes,Norditerpenoid,Cembranes,Diterpenoids,Labdanes,Norditerpenoids,Cembrane Diterpenes,Diterpene, Labdane,Labdane Diterpenes
D000097567 Pleuromutilins A tricyclic diterpene natural product isolated from Pleurotus mutilus (now referred to as Clitopilus scyphoides). Possesses modest antibacterial activity against primarily gram-positive bacterial organisms. Octahydro-5,8-dihydroxy-4,6,9,10- tetramethyl-6-vinyl-3a,9-propano-3aH-cyclopenta- cycloocten-1(4H)-one 8-glycolate,Pleuromutilin,Pleuromutilin Antibiotics,Drosophilin B
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D055624 Methicillin-Resistant Staphylococcus aureus A strain of Staphylococcus aureus that is non-susceptible to the action of METHICILLIN. The mechanism of resistance usually involves modification of normal or the presence of acquired PENICILLIN BINDING PROTEINS. MRSA,Methicillin Resistant Staphylococcus aureus

Related Publications

Qi Wang, and Jie Liu, and Zi-Dan Zhou, and Ke-Xin Zhou, and Fei Li, and Qi-Wen Zhang, and Shou-Kai Wang, and Wei Wang, and Zhen Jin, and You-Zhi Tang
May 2024, ACS infectious diseases,
Qi Wang, and Jie Liu, and Zi-Dan Zhou, and Ke-Xin Zhou, and Fei Li, and Qi-Wen Zhang, and Shou-Kai Wang, and Wei Wang, and Zhen Jin, and You-Zhi Tang
October 2012, Bioorganic & medicinal chemistry letters,
Qi Wang, and Jie Liu, and Zi-Dan Zhou, and Ke-Xin Zhou, and Fei Li, and Qi-Wen Zhang, and Shou-Kai Wang, and Wei Wang, and Zhen Jin, and You-Zhi Tang
December 2023, Journal of enzyme inhibition and medicinal chemistry,
Qi Wang, and Jie Liu, and Zi-Dan Zhou, and Ke-Xin Zhou, and Fei Li, and Qi-Wen Zhang, and Shou-Kai Wang, and Wei Wang, and Zhen Jin, and You-Zhi Tang
January 2020, Chemical & pharmaceutical bulletin,
Qi Wang, and Jie Liu, and Zi-Dan Zhou, and Ke-Xin Zhou, and Fei Li, and Qi-Wen Zhang, and Shou-Kai Wang, and Wei Wang, and Zhen Jin, and You-Zhi Tang
October 2015, Yao xue xue bao = Acta pharmaceutica Sinica,
Qi Wang, and Jie Liu, and Zi-Dan Zhou, and Ke-Xin Zhou, and Fei Li, and Qi-Wen Zhang, and Shou-Kai Wang, and Wei Wang, and Zhen Jin, and You-Zhi Tang
December 2020, Bioorganic chemistry,
Qi Wang, and Jie Liu, and Zi-Dan Zhou, and Ke-Xin Zhou, and Fei Li, and Qi-Wen Zhang, and Shou-Kai Wang, and Wei Wang, and Zhen Jin, and You-Zhi Tang
February 2018, Computational biology and chemistry,
Qi Wang, and Jie Liu, and Zi-Dan Zhou, and Ke-Xin Zhou, and Fei Li, and Qi-Wen Zhang, and Shou-Kai Wang, and Wei Wang, and Zhen Jin, and You-Zhi Tang
November 2023, Drug development research,
Qi Wang, and Jie Liu, and Zi-Dan Zhou, and Ke-Xin Zhou, and Fei Li, and Qi-Wen Zhang, and Shou-Kai Wang, and Wei Wang, and Zhen Jin, and You-Zhi Tang
June 2020, RSC advances,
Qi Wang, and Jie Liu, and Zi-Dan Zhou, and Ke-Xin Zhou, and Fei Li, and Qi-Wen Zhang, and Shou-Kai Wang, and Wei Wang, and Zhen Jin, and You-Zhi Tang
August 2020, Chemical biology & drug design,
Copied contents to your clipboard!